Table 2 TP53 and survivin expression in ovarian carcinomas.
| Â | ALL PATIENTS | TP-TREATED GROUP | PC/PAC-TREATED GROUP |
|---|---|---|---|
| Â | N = 435 | N = 191 | N = 244 |
TP53-positive carcinomas | 255 (59%) | 110 (58%) | 145 (59%) |
TP53-negative carcinomas | 180 (41%) | 81 (42%) | 99 (41%) |
Cytoplasmic survivin expression: | Â | Â | Â |
Low (0 + 1 scores) | 363 (83%) | 149 (78%) | 214 (82%) |
High (2 + 3 scores) | 72 (17%) | 42 (22%) | 30 (18%) |
Nuclear survivin expression: | Â | Â | Â |
ID score < 1.5 | 268 (62%) | 97 (51%) | 171 (70%) |
ID score ≥ 1.5 | 167 (38%) | 94 (49%) | 73 (30%) |